One, Project Overview
BIO Protocol is an innovative platform for decentralized science (DeSci) dedicated to funding and commercializing scientific research in the biotechnology field. Through this protocol, global patients, scientists, and biotechnology investors can collaboratively fund, create, and own tokenized biotechnology projects and intellectual property (IP), thereby accelerating advancements in biotechnology.
BIO Protocol aims to address many pain points in traditional scientific research funding and biotechnology commercialization, including time-consuming funding processes, the 'Valley of Death' for early research results, funding centralization, intellectual property barriers, and insufficient patient engagement. Through decentralized funding models, capital efficiency improvements, global resource integration, and shared intellectual property, BIO Protocol is injecting new vitality into biotechnology innovation.
Two, Market Pain Points and BIO Protocol's Solutions
1. Market Pain Points
Time-consuming funding processes: Scientists spend a significant amount of time applying for funding, affecting research efficiency.
The 'Valley of Death' phenomenon: Many early discoveries fail to commercialize due to high risks, lack of resources, and insufficient support.
Centralization of funding: Research funding is concentrated in a few geographic areas, limiting the potential of global scientific talent.
Complex intellectual property barriers: Dispersed ownership of intellectual property and licensing agreements hinder collaboration and innovation.
Insufficient patient engagement: Most research is disconnected from patient communities and fails to establish consistent incentive mechanisms.
2. Solutions of BIO Protocol
Decentralized Funding: Allows anyone to invest in promising biotechnology projects.
Capital Efficiency Improvement: Aggregates patient data, capital, and human resources to reduce innovation costs.
Diversified Portfolio: Reduces biotechnology investment risks through portfolio investment.
Global Resource Integration: Attracts global scientists and investors to participate in projects.
Shared Intellectual Property: Achieves co-ownership of intellectual property through tokenization.
Liquidity Market: Provides early liquidity for traditionally illiquid biotechnology assets.
Open Rights: Eliminates intermediaries in scientific funding and decision-making.
Three, the core functions of BIO Protocol
1. BIO Launchpad
BIO Launchpad is one of the core functions of BIO Protocol, divided into three phases:
Governance Phase: BIO holders vote to decide which BioDAO projects can be launched through BIO Protocol.
Acceleration Phase: Projects raise their first funds through auction or joint curve mechanisms.
Separation Phase: Projects enter the public market through on-chain liquidity pools, with BIO Protocol providing liquidity support.
2. BioDAO Launchboard
BIO Protocol supports the creation and development of BioDAO, helping it complete legal governance frameworks, brand building, and the deployment of Web3 tools. BIO provides financial support and AI tools to BioDAO in collaboration with Catalyst and Pump.science.
3. Liquidity Protocols
BIO Protocol provides deep on-chain liquidity pools, supporting liquidity trading of BioDAO tokens with ETH, promoting the healthy development of the DeSci ecosystem.
4. Tokenized Intellectual Property
BIO Protocol tokenizes scientific intellectual property, granting it liquidity so that investors can participate in the value creation of biotechnology assets earlier.
Four, Token Economics of BIO Protocol
1. Token Distribution
The governance token of BIO Protocol is BIO, based on the ERC-20 standard, with a total supply of 3,320,000,000 tokens, allocated as follows:
Team: 21.20%
Advisors: 4.70%
Private Investors: 13.60%
Community Auction: 20.00%
Community Airdrop: 6.00%
Ecosystem Incentives: 19.00%
Liquidity and Marketing: 2.50%
Binance Launchpool: 3.00%
2. Token Functions
Governance Rights: BIO holders can participate in protocol governance, including the meta-governance of BioDAO.
Whitelist Access: BIO holders have priority participation in BioDAO financing rounds and investment opportunities in tokenized IP.
Curatorial Management: BIO holders decide which BioDAO projects can be launched through the BIO Launchpad.
Protocol Liquidity: BIO Protocol utilizes BioDAO tokens and IP tokens in its treasury to provide liquidity and earn transaction fees.
3. Token Issuance Schedule
BIO Protocol adopts a phased release of tokens to ensure market stability and healthy ecosystem development.
Five, Financing Situation and Key Indicators
1. Financing Situation
BIO Protocol has completed multiple rounds of private and public financing:
Private Financing:
Pre-seed round: Raised $900,000, with a valuation of approximately $35 million.
Seed round: Raised $1.4 million, with a valuation of approximately $69 million.
Public Financing:
Genesis Round 1: Raised $6.2 million, with a valuation of approximately $85 million.
Genesis Round 2: Raised $18.2 million, with a valuation of approximately $142 million.
Genesis Round 2.5: Raised $3.5 million, with a valuation of approximately $219 million.
2. Key Indicators (as of December 24, 2024)
Initial Circulation: 1,296,529,168 tokens (accounting for 39.05% of the total)
Maximum Circulation: 3,320,000,000 tokens
Binance Launchpool Quota: 99,600,000 tokens (accounting for 3.00% of the total)
Six, Roadmap and Future Plans
1. Completed Milestones
Q2 2024: BIO Protocol launch and community airdrop.
Q3-Q4 2024: Complete multiple rounds of Genesis auctions.
Q4 2024: Launch DeSci dashboard and Quantum Biology auction.
2. Future Plans
January 2025:
Launch on centralized exchanges (CEX).
Launch DeSci AI agents.
Release $BIO on Ethereum, Solana, and Base chains.
Initiate $BIO/BioDAO liquidity pool.
February 2025:
Launch BIO Launchpad v1.
Deploy management mechanisms on EVM chains and Solana.
Launch the Curetopia platform.
Seven, Business Cooperation and Ecosystem
BIO Protocol actively collaborates with industry-leading institutions to jointly promote the development of the DeSci ecosystem:
Molecule AG: Provides IP-NFT and IP tokenization frameworks.
ResearchHub: Supports a decentralized peer review platform.
Pump.Science: Provides distributed research protocol services.
Pfizer Venture Capital: Promotes the commercialization of biotechnology projects.
Eight, Summary and Analysis
BIO Protocol is a pioneer in the field of decentralized science, addressing pain points in research funding and biotechnology commercialization through tokenization and decentralization. Its core functions, BIO Launchpad and liquidity protocols, provide strong support for biotechnology innovation while attracting a wide range of investors and scientists through token economics and global resource integration.
From a future development perspective, BIO Protocol's roadmap is clear, with defined goals, especially showing great potential in areas such as DeSci AI agents, cross-chain deployment, and the Curetopia platform. As the BIO Protocol ecosystem continues to grow, its influence in the field of decentralized science will also continue to rise.
Overall, BIO Protocol is a project with disruptive potential that not only brings new possibilities for scientific research and biotechnology commercialization but also provides global investors with opportunities to participate in cutting-edge scientific research.
Remarks:
My invitation link: https://www.suitechsui.io/cn/join?ref=HYERS7S4
#Binance